The Board of Directors at their meeting held on 17th February 2026 has approved the appointment of Mr. Amarendra Mohapatra as a Senior Management Personnel designated with the position ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mahamaya Lifesciences Ltd announced that its Board of Directors, at a meeting held on February 17, 2026, approved the appointment of Mr. Amarendra Mohapatra as Vice President – Finance & Accounts, designated as a Senior Management Personnel (SMP). Mr. Mohapatra is a qualified Chartered Accountant and Law Graduate with over 17 years of experience spanning finance, audit, taxation, regulatory compliance, and corporate governance. His background also includes IPO execution, M&A transactions, due diligence with leading audit firms, treasury management, and compliance with SEBI, RBI, FEMA, and Companies Act regulations. The appointment was disclosed under SEBI LODR Regulation 30 and signed by Shilpi Bhardwaj, Company Secretary.
This is a routine senior-level appointment that strengthens the company's finance and compliance leadership. For shareholders, the hiring of an experienced finance professional with IPO and M&A expertise signals preparation for potential fundraising or strategic transactions, though it is unlikely to cause immediate stock price movement.